You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

136 search results for: type 2 inflammation

Understanding the Pathophysiology of Pediatric <b>Type</b> <b>2</b> Inflammatory Diseases
expert video

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases

Type 2 Inflammation
Prof. Oscar Palomares discusses the underlying pathophysiology of type 2 inflammation in pediatric patients with AD, asthma, or EoE.
View more
Targeting <b>Type</b> <b>2</b> <b>Inflammation</b> in Children with AD​
expert video

Targeting Type 2 Inflammation in Children with AD​

Dermatology
The impact of type 2 inflammation in itch and barrier dysfunction in atopic dermatitis – Presentation from the ADVENT symposium at EAACI 2023.
View more
Skin Barrier, Neuroimmune Axis, and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis - Q&As
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis - Q&As

Dermatology
Expert insights on the plasticity of inflammation, atopic dermatitis endotypes, and dysbiosis – Audience Q&A from the ADVENT symposium at ISID 2023.
View more
How Does Protective <b>Type</b> <b>2</b> Immunity Become Harmful <b>Type</b> <b>2</b> <b>Inflammation</b>?
expert video

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

Dermatology
In this video from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson discusses how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation. The associated inflammatory process can contribute to the pathophysiology of several dermatological diseases, including AD, PN, CSU, and BP.
View more
Targeting <b>Type</b> <b>2</b> <b>Inflammation</b>: ​Skin Barrier Normalization​
expert video

Targeting Type 2 Inflammation: ​Skin Barrier Normalization​

Dermatology
Highlights from ESPD 2023 ADVENT: Uncovering how type 2 inflammation influences skin barrier dysfunction in atopic dermatitis.
View more
Skin Barrier, Neuroimmune Axis, and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

Dermatology
Presentations from the ADVENT symposium at the ISID 2023 meeting on the skin barrier, neuroimmune axis, and type 2 inflammation in atopic dermatitis.
View more
Targeting Underlying <b>Inflammation</b> in CRSwNP, a <b>Type</b> <b>2</b> Inflammatory Disease
expert video

Targeting Underlying Inflammation in CRSwNP, a Type 2 Inflammatory Disease

Rhinology
Professor Martin Wagenmann describes the mechanisms through which type 2 inflammation drives symptoms in patients with CRSwNP.
View more
Expert Case Series: What is the Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Skin Barrier Dysfunction Commonly Observed in Atopic Dermatitis?
interactivity

Expert Case Series: What is the Role of Type 2 Inflammation in Skin Barrier Dysfunction Commonly Observed in Atopic Dermatitis?

Dermatology
Gain insights with Prof. Lisa Beck: Explore the link between skin barrier dysfunction and type 2 inflammation in atopic dermatitis.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> in AD Manifestations in Skin and Body
expert video

Type 2 Inflammation in AD Manifestations in Skin and Body

Dermatology
Dr. Ramien discusses the role of type 2 inflammation in the pathophysiology of atopic dermatitis, and highlights the association of atopic dermatitis with systemic diseases and comorbidities.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> and Neuronal Sensitization in AD and PN
interactivity

Type 2 Inflammation and Neuronal Sensitization in AD and PN

Dermatology
Mechanisms of itch in normal skin and the effect of type 2 inflammation on neurons leading to chronic itch in atopic dermatitis and prurigo nodularis.
View more
What Do We Know About <b>Type</b> <b>2</b> <b>Inflammation</b> in COPD?
expert video

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology
Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.
View more
The Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis
expert video

The Role of Type 2 Inflammation in Atopic Dermatitis

Dermatology
The impact of type 2 inflammation and barrier dysfunction in the pathogenesis of chronic disease in atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region